Read Time:8 Second
Wall Street urged Pfizer to lower its COVID revenue estimates. The company did — but it’s still betting on higher demand for its vaccine and antiviral by 2025.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
